The most commonly observed coagulopathy associated with COVID-19 is characterized by initially increased D-dimer and fibrinogen levels while prolonged prothrombin time, and partial thromboplastin time with decreased platelet count were uncommon at that initial presentation. Here, F2 is linked to COVID-19.